- Published on
What Is a Diet Supplement? Definitions, UK Regulation, and What the Evidence Requires
- Authors

- Name
- Metabolic Boost Diets Editorial Team
"Diet supplement" is an umbrella term covering a wide range of products with very different evidence bases, mechanisms, and regulatory statuses. Understanding the legal definition, the regulatory framework, and what evidence standards apply prevents both over-reliance on products that do not work and under-use of those that have genuine utility.
The Legal Definition in the UK
Food Supplements (England) Regulations 2003 defines food supplements as:
"Any foodstuff the purpose of which is to supplement the normal diet and which is a concentrated source of a nutrient or other substance with a nutritional or physiological effect, alone or in combination, marketed in dose form, namely capsules, pastilles, tablets, pills and other similar forms, sachets of powder, ampoules of liquids, drop dispensing bottles, and other similar forms of liquids and powders designed to be taken in measured small unit quantities."
Key elements of this definition:
- Supplement — intended to add to dietary intake, not replace food
- Concentrated source — more concentrated than typical food
- Dose form — capsule, tablet, powder, sachet; not a conventional food
- Nutritional or physiological effect — not a pharmacological (medicinal) effect
This last distinction — nutritional/physiological vs. pharmacological — is the legal boundary between a supplement and a medicine.
Diet Supplements vs. Medicines: The Regulatory Boundary
Medicines (regulated by the MHRA under the Medicines Act 1968 and Human Medicines Regulations 2012): Products that claim to treat, cure, prevent, or diagnose disease. Require a marketing authorisation — evidence of efficacy and safety is mandatory before sale.
Food supplements (regulated by the Food Standards Agency under the Food Supplements Regulations): Products that claim to support normal physiological function. Do not require demonstration of efficacy — only safety and accurate labelling.
The grey area: A supplement claiming to "reduce cholesterol" is making a borderline claim that may trigger MHRA scrutiny (as lowering cholesterol could imply a medicinal function). A supplement claiming to "contribute to normal lipid metabolism" is a nutritional claim within supplement territory — even if the underlying implication to consumers is similar.
This regulatory gap is why supplement marketing often uses specific language: "supports," "contributes to," "helps maintain" — words that stop short of medicinal claims but suggest benefit.
Categories of Diet Supplement
1. Vitamins and minerals The most straightforward category. Permitted forms and maximum amounts are specified in Annexes to the Food Supplements Regulations. EFSA has evaluated thousands of vitamin and mineral health claims — many are authorised (e.g., "vitamin C contributes to normal immune function"). These are the most clearly regulated category.
2. Protein supplements Protein powders (whey, casein, plant-based) are classified as food ingredients rather than supplements in most formulations. They supply a macronutrient at high concentration. Evidence base for protein at adequate intake (1.6–2.0g/kg/day) for muscle preservation and satiety is strong and derived from food studies — the supplement form is equivalent to food protein when dose is matched.
3. Herbal and botanical supplements Regulated separately under the Traditional Herbal Medicines Directive (THMPD) for those making medicinal claims. When sold as food supplements without medicinal claims, the same Food Supplements Regulations apply. Evidence quality varies enormously across this category — from well-studied ingredients (ginger for nausea, validated by RCOG) to ingredients with no human evidence.
4. Weight management supplements The category most subject to overclaiming. EFSA has rejected weight loss claims for the majority of ingredients commonly marketed for this purpose (raspberry ketones, Garcinia cambogia/HCA, green coffee bean extract, green tea catechins as a category). The only EFSA-authorised weight management supplement is glucomannan (EFSA 2009/2010 — 1g × 3/day before meals with 250ml water, within an energy-restricted diet).
5. Sports supplements Protein, creatine, caffeine, and carbohydrate formulations for athletic performance. Creatine monohydrate has the most consistent evidence base in this category (Buford et al. 2007, ISSN position paper): 3–5g/day increases phosphocreatine stores, improving high-intensity performance. This is distinct from weight management.
6. Speciality supplements (omega-3, probiotics, CoQ10, etc.) Omega-3 (EPA/DHA): EFSA-authorised claims for maintenance of normal cardiac function (250mg/day EPA + DHA) and normal triglycerides (2–4g/day EPA + DHA). Probiotics: no EFSA-authorised health claims exist in the EU/UK as of 2024 — all submitted probiotic claims were rejected for insufficient evidence specificity. CoQ10: no EFSA-authorised claims for general health.
How Evidence Quality Varies Across Supplements
The same product category can contain ingredients with evidence at opposite ends of the spectrum:
| Supplement type | Strongest evidence | No meaningful evidence |
|---|---|---|
| Vitamins | Vitamin D for bone health, immune function | Megadose vitamin C for immune boost |
| Weight management | Glucomannan (EFSA authorised) | Raspberry ketones, HCA, detox blends |
| Herbal | Ginger for nausea (RCOG), St John's Wort for mild depression | Proprietary "metabolism boosting" blends |
| Sports performance | Creatine monohydrate, caffeine, protein | BCAAs (when protein is adequate), many pre-workout ingredients |
| Gut health | Fermented foods (indirect evidence) | Most probiotic supplements (no EFSA authorised claims) |
What the Evidence Requires (That Marketing Doesn't)
For a supplement to have genuine evidence behind a specific claim, the research needs to meet a minimum standard:
- Human RCTs — not just cell culture or animal studies
- Adequate sample size — typically n>50 for metabolic outcomes; single small studies are insufficient
- Pre-specified primary outcomes — not post-hoc claims
- Appropriate comparator — placebo or active control
- Effect size that is clinically meaningful — statistical significance in small studies can represent effects too small to matter
- Replication — one positive RCT is not enough; consistent findings across independent research groups
The EFSA evaluation process uses a version of these criteria applied by scientific panels. Products that have passed this scrutiny for specific claims have met a meaningful evidence bar. Products that avoid EFSA claims (using vague language instead) have typically not.
Practical Assessment Before Purchasing a Diet Supplement
| Question | What to look for |
|---|---|
| What specific claim is made? | Authorised EFSA claim vs. vague "supports" language |
| What is the active ingredient? | Named, single ingredient with published research |
| Is it at the evidence-based dose? | Compare product dose to dose used in research |
| What is the evidence source? | Human RCTs > animal studies > in vitro |
| Does food provide the same? | Food first — supplements fill gaps, not replace food |
| Has a GP or dietitian confirmed a need? | Essential for correcting documented deficiencies |
Disclaimer: This article is for informational and educational purposes only. Specific supplement choices should be guided by a GP or registered dietitian, especially if you have existing health conditions or take prescription medications.